{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T23:16:00Z","timestamp":1770333360019,"version":"3.49.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Medicine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.imj.2024.100087","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T13:12:08Z","timestamp":1706793128000},"page":"100087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["HBsAg kinetics after 7 years of therapy with tenofovir disoproxil fumarate in a cohort of na\u00efve patients affected by chronic hepatitis B with different genotypes"],"prefix":"10.1016","volume":"3","author":[{"given":"Lucio","family":"Boglione","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Lupia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Stroffolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Dodaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni Di","family":"Perri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imj.2024.100087_bib0001","doi-asserted-by":"crossref","first-page":"18035","DOI":"10.1038\/nrdp.2018.35","article-title":"Hepatitis B virus infection","volume":"4","author":"Yuen","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"2","key":"10.1016\/j.imj.2024.100087_bib0002","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.imj.2024.100087_bib0003","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1136\/gut.2004.060327","article-title":"Response to interferon Alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D","volume":"54","author":"Erhardt","year":"2005","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.imj.2024.100087_bib0004","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1053\/j.gastro.2009.08.061","article-title":"Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa","volume":"137","author":"Buster","year":"2009","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.imj.2024.100087_bib0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jinf.2014.02.018","article-title":"The E genotype of hepatitis B: clinical and virological characteristics, and response to interferon","volume":"69","author":"Boglione","year":"2014","journal-title":"J. Infect."},{"key":"10.1016\/j.imj.2024.100087_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104973","article-title":"HBV evolution and genetic variability: impact on prevention, treatment and development of antivirals","volume":"186","author":"Glebe","year":"2021","journal-title":"Antiviral Res"},{"issue":"3","key":"10.1016\/j.imj.2024.100087_bib0007","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3138\/canlivj-2023-0003","article-title":"Hepatitis B virus genotypes influence clinical outcomes: a review, Can","volume":"6","author":"Fernandes da Silva","year":"2023","journal-title":"Liver J"},{"issue":"11","key":"10.1016\/j.imj.2024.100087_bib0008","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/jmv.24038","article-title":"Different HBsAg decline after 3 years of therapy with entecavir in patients affected by chronic hepatitis B HBeAg-negative and genotype A, D and E","volume":"86","author":"Boglione","year":"2014","journal-title":"J. Med. Virol."},{"issue":"4","key":"10.1016\/j.imj.2024.100087_bib0009","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s00705-021-04992-5","article-title":"Serological and virological response in patients with hepatitis B virus genotype E treated with entecavir or tenofovir: a prospective study","volume":"166","author":"Boglione","year":"2021","journal-title":"Arch. Virol."},{"issue":"4","key":"10.1016\/j.imj.2024.100087_bib0010","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/liv.12091","article-title":"Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D","volume":"33","author":"Boglione","year":"2013","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.imj.2024.100087_bib0011","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3748\/wjg.v13.i1.14","article-title":"Hepatitis B virus taxonomy and hepatitis B virus genotypes","volume":"13","author":"Schaefer","year":"2007","journal-title":"World J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.imj.2024.100087_bib0012","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1111\/apt.14636","article-title":"Impact of HBV genotype and mutations on HBV DNA and qHBsAg levels in patients with HBeAg-negative chronic HBV infection","volume":"47","author":"Kuhnhenn","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.imj.2024.100087_bib0013","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bpg.2017.04.010","article-title":"Natural history of acute and chronic hepatitis B: The role of HBV genotypes and mutants","volume":"31","author":"Lin","year":"2017","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"10","key":"10.1016\/j.imj.2024.100087_bib0014","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41575-020-0296-6","article-title":"The evolution and clinical impact of hepatitis B virus genome diversity","volume":"17","author":"Revill","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."}],"container-title":["Infectious Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772431X24000017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772431X24000017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T10:46:03Z","timestamp":1757414763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772431X24000017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2772431X24000017"],"URL":"https:\/\/doi.org\/10.1016\/j.imj.2024.100087","relation":{},"ISSN":["2772-431X"],"issn-type":[{"value":"2772-431X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HBsAg kinetics after 7 years of therapy with tenofovir disoproxil fumarate in a cohort of na\u00efve patients affected by chronic hepatitis B with different genotypes","name":"articletitle","label":"Article Title"},{"value":"Infectious Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imj.2024.100087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of Tsinghua University Press.","name":"copyright","label":"Copyright"}],"article-number":"100087"}}